Zhipeng Li

5.2k citations
49 papers · 4.1k · 1 hit paper · h-index 20

Impact in

Papers in

Zhipeng Li

47 papers receiving 4.0k citations

Zhipeng Li's Hit Papers

The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis 2019 · 2.8k citations
2.8k0+2+4Years since publication50010001.5k2.0k2.5k

Peers

Zhipeng Li
Comparison fields: 5 of 123
  • Cancer Research 1.6k
  • Pulmonary and Respiratory Medicine 2.4k
  • Molecular Biology 2.2k
  • Biochemistry 199
  • Oncology 367
Replace Hyemin Lee with:
Hyemin Lee United States
Fereshteh Zandkarimi United States
Leslie Magtanong United States
Yang Xie China
Tongyuan Li United States
Rohitha Sriramaratnam Switzerland
Chao Mao China
Jiao Wu China
Prashant Monian United States
Bettina Proneth Germany
Zhipeng Li relative to Hyemin Lee United States Hyemin Lee's profile →
Citations per field
00.5×
Hyemin Lee · 1×
Citations per year

Countries citing papers authored by Zhipeng Li

Since Specialization
Citations

This map shows the geographic impact of Zhipeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhipeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhipeng Li more than expected).

Fields of papers citing papers by Zhipeng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhipeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhipeng Li. The network helps show where Zhipeng Li may publish in the future.

Co-authors

The 25 scholars most cited alongside Zhipeng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zhipeng Li Line = papers co-authored together Zhipeng Li links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
Hit paper breakdown →
20192796
2 2016144
3 2013140
4 202087
5 202287
6 202375
7 201572
8 201971
9 201657
10 202344
11
microRNA-137 modulates pancreatic cancer cells tumor growth, invasion and sensitivity to chemotherapy.
201440
12 201439
13 201328
14 202128
15 202125
16 202024
17 202222
18 201921
19 201920
20 201820

About Zhipeng Li

Zhipeng Li is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Biochemistry and Epidemiology, having authored 49 papers that have together received 4.1k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Autophagy in Disease and Therapy (4 papers), Cancer-related molecular mechanisms research (4 papers), MicroRNA in disease regulation (4 papers), RNA modifications and cancer (4 papers), Molecular Sensors and Ion Detection (3 papers) and Winter Sports Injuries and Performance (3 papers). The work is most often cited by research in Cancer Research (1.6k citations), Pulmonary and Respiratory Medicine (2.4k citations), Molecular Biology (2.2k citations), Biochemistry (199 citations) and Oncology (367 citations). Zhipeng Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include James A. Olzmann, Scott J. Dixon, Melissa A. Roberts, Joseph M. Hendricks, Leslie Magtanong, Michael C. Bassik, Kirill Bersuker, Daniel K. Nomura, Roberto Zoncu and Thomas J. Maimone. Their work appears in journals such as Journal of Orthopaedic Translation, Cancer Cell International, Frontiers in Pharmacology, Nature Chemical Biology and Enzyme and Microbial Technology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact